Q&A with Judith Ng-Cashin, CRO Novotech’s chief medical officer, on 2023 and beyond

Last month, Ju­dith Ng-Cashin be­came Novotech’s first chief med­ical of­fi­cer, with an eye to­ward ex­pand­ing the Asia-Pa­cif­ic con­tract re­search or­ga­ni­za­tion (CRO) far­ther West.

Ng-Cashin, who brings two decades of in­ter­na­tion­al phar­ma, biotech and CRO ex­pe­ri­ence to lead Novotech’s glob­al med­ical ser­vices team, chat­ted with End­points News on Fri­day re­gard­ing the cur­rent land­scape for CROs, biotech com­pa­nies and more. This con­ver­sa­tion has been edit­ed and con­densed for clar­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.